Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-06

Clinical Trial Update: Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bright white light therapy to reduce cancer-related fatigue and depression in advanced/metastatic prostate cancer patients on androgen …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: City of Hope Medical Center | Conditions: Advanced Prostate Carcinoma, Metastatic Prostate Carcinoma | Phase 2 | Status: RECRUITING